Dewhurst Share News (DWHT)

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

Dewhurst First Half Profit Rise Driven By Lift Business

LONDON (Alliance News) - Dewhurst PLC Tuesday reported higher profits and revenues for the first half of its financial year, driven by a strong trading performance from its lift business and a stabilisation in sales within its transport and keypad divisions. The company, which supplies comp

UPDATE: Dewhurst Subsidiary Defending USD7M Product Failure Claim

LONDON (Alliance News) - Dewhurst PLC Friday said its Hungarian subsidiary would defend a USD7 million complaint from AIG Speciality Insurance over a product failure with the "utmost vigour." Dewhurst said that Dewhurst Hungary KFT has received a complaint from AIG Specialty Insurance, clai

Dewhurst Subsidiary Defending USD7M Claim Against It By AIG Specialty Insurance

LONDON (Alliance News) - Dewhurst PLC Friday said one of its subsidiary's has received a complaint against it by AIG Specialty Insurance, claiming USD7 million in respect of a purported product failure of a component supplied to a third party. The company, which supplies quality components

Monday broker round-up -UPDATE

Afferro Mining Inc: Investec retains buy recommendation and target price at 107p. Antrim Energy Inc.: Westhouse Securities keeps buy recommendation and target price at 70p. ASOS: Investec ups target from 2,450p to 2,675p, buy rating kept. Aveva: Investec keeps buy rating and 2,200p target. Bovis

Dewhurst profits to beat expectations

Dewhurst, an independent supplier of quality components to the lift, keypad and transport industries, has said its pre-tax profit for the year ended September 30th will be significantly ahead of market expectations, which is largely due to better-than-expected sales both in the UK and overseas. Ja

Small caps round-up: Geong, Orosur Mining, XG Technology...

Chinese software and internet solutions provider Geong reported a 28% slump in turnover for the six months ended 30 September to £4.7m, though profits rose 17% to £0.7m. Chief executive Wang Weidong called it a "satisfactory" set of interim results and said the company expects full-year numbers to

Dewhurst beats expectations

Better than expected sales in Europe and Asia mean that components supplier Dewhurst will report significantly higher than expected profit for the year to September 2010. House broker Seymour Pierce originally forecast a profit of £3.6m for the year, which would have been a decline from £4.43m. An

Dewhurst Concludes Talks With Employees For Closing Pension Scheme

LONDON (Dow Jones)--Dewhurst PLC (DWHT.LN), a manufacturer of electrical components and control equipment for industrial and commercial capital goods, and supplier of lift equipment, said Thursday it concluded a two month consultation period with employees on July 7 over its proposal to close the gr

UK Lift Parts Firm Dewhurst Takes Step To Buy Out US Peers

LONDON (Dow Jones)--Lift component maker Dewhurst PLC (DWHT.LN) said Wednesday that it had taken the first steps toward the acquisition of a pair of Los Angeles-based companies, a move that may sharply lift its revenues from North America close to that of its main market in the U.K. The London-h

Dewhurst Plc Acquisitions

TIDMDWHT RNS Number : 4210O Dewhurst PLC 30 June 2010 Dewhurst PLC (the "Company" or "Dewhurst") Acquisition of stakes in Elevator Research & Manufacturing Corp. and Winter & Bain Manufacturing, Inc. Dewhurst PLC, an independent supplier of quality

Dewhurst: John Bailey Appointed Executive Director

LONDON (Dow Jones)--Dewhurst PLC (DWHT.LN), said Friday it has appointment John Bailey as an Executive Director of with immediate effect. MAIN FACTS: -John Bailey is currently Managing Director of Traffic Management Products Ltd and Cortest Ltd and although he will retain his current duties

Thursday's tips round-up: Imperial Innovations, Barratt, Autonomy

Imperial Innovations is starting to make strong gains on exits from its portfolio, selling Thiakis, the developer of an anti-obesity drug, to America's Wyeth and, last week, disposing of Respivert, the maker of a respiratory treatment, to an offshoot of Johnson & Johnson. At 474½p, tuck away. The I